Dr_Marek_Zielinski
Here for the chemistry, staying for the arguments about estimands.
27kreputation
80answers
11accepted
17questions
0·2·7badges g·s·b
68tags
142Is potassium a better monitoring choice than lipase on cagrilintide?accepted · answered 6 Jul 2025 · bloodwork, kidney-function, lipids115Is early satiety on liraglutide dose-dependent or dose-rate dependent?accepted · answered 12 Nov 2025 · gi-side-effects, titration, liraglutide100What did the placebo arm of STEP 1 report for early satiety?accepted · answered 14 Jan 2025 · clinical-trials, gi-side-effects92When does fatigue stop being a tolerability issue and become a clinical one?accepted · answered 12 Dec 2025 · harm-reduction, fatigue, pancreatitis75Is lipase worth drawing at baseline before starting a GLP-1 receptor agonist?answered 31 Mar 2025 · bloodwork, harm-reduction, a1c72Why did my LDL-C rise 22% during the fastest phase of weight loss?accepted · answered 1 Aug 2025 · lipids, bloodwork, gallbladder67Does reflux at week seven of a GLP-1 receptor agonist usually resolve without a dose change?accepted · answered 27 Apr 2025 · gi-side-effects, titration63At what point does upper abdominal pain warrant urgent assessment?answered 31 Oct 2024 · pancreatitis, gi-side-effects, harm-reduction60What does peptide mapping add for semaglutide that a purity figure does not?answered 17 Dec 2024 · content-assay, purity, coa59What does SUSTAIN-6 tell me about reflux at the 2 mg dose?answered 7 Oct 2024 · clinical-trials, gi-side-effects, titration54What did STEP 1 do with participants who could not tolerate a step?accepted · answered 12 Feb 2025 · titration, clinical-trials, gi-side-effects50What is the thermal exposure on a Qingdao to South Africa lane in summer?answered 26 Jan 2025 · cold-chain, international-shipping, storage49Does lipase tell me anything about hepatic fat on cagrilintide?answered 16 May 2025 · liver-enzymes, mash, bloodwork47What is the dead-space loss per draw with a 29G needle at 4 mg/mL?answered 16 Dec 2025 · dead-space, insulin-syringe, dosing-math45What did the placebo arm of TRIUMPH-3 report for constipation?answered 4 Nov 2024 · clinical-trials, constipation41Is ALT a better monitoring choice than AST on survodutide?answered 4 May 2025 · bloodwork, kidney-function, lipids40Does holding at 5 mg for six weeks before escalating reduce fatigue?answered 18 Jan 2025 · titration, fatigue, dose-escalation40Why did my lipase move after two weeks on semaglutide?answered 3 Dec 2024 · bloodwork, kidney-function, lipids39How do I check that two ERP lots of cagrilintide agree on content assay?answered 5 Dec 2025 · batch-testing, content-assay, vendor-vetting39How do I tell biliary colic from ordinary upper-abdominal discomfort?answered 12 Jul 2024 · gallbladder, gi-side-effects, harm-reduction38How does ERP compare to Nantong Guangyuan Chemical on documentation quality?answered 25 Sept 2025 · vendor-comparison, coa, vendor-vetting38Is STEP 8 a fair comparison of semaglutide against its comparator arm?answered 21 Jul 2025 · clinical-trials, semaglutide, tirzepatide38Is ursodeoxycholic acid prophylaxis supported by anything in this population?answered 19 Jul 2024 · gallbladder, clinical-trials, harm-reduction37Does MKM issue lot-specific documentation, or a batch certificate?answered 12 Dec 2024 · batch-testing, coa, vendor-vetting35Does lipase tell me anything about hepatic fat on a GLP-1 receptor agonist?answered 9 Aug 2024 · liver-enzymes, mash, bloodwork35How does survodutide behave on a C4 column compared to tirzepatide?answered 28 Mar 2024 · hplc, purity, reference-standard34What fraction of loss on retatrutide is lean mass according to TRIUMPH-1?answered 5 Aug 2024 · lean-mass, muscle-loss, dexa33Is lipase worth drawing at baseline before starting mazdutide?accepted · answered 5 Jul 2025 · bloodwork, harm-reduction, a1c33What does FLOW tell me about dizziness at the 1 mg dose?answered 4 Apr 2024 · clinical-trials, titration31What did SURMOUNT-1 do with participants who could not tolerate a step?accepted · answered 18 Jun 2026 · titration, clinical-trials, gi-side-effects31What is the reported incidence of reflux on retatrutide in TRIUMPH-3?answered 12 Aug 2025 · gi-side-effects, clinical-trials, retatrutide28What is the reported incidence of reflux on semaglutide in STEP 3?answered 25 Dec 2024 · gi-side-effects, clinical-trials, semaglutide27How do I reconcile 96.8% from Medutest with 97.6% from the supplier?answered 29 Jul 2025 · purity, batch-testing, coa27What interval makes sense for repeating lipase on cagrilintide?answered 23 Apr 2025 · bloodwork, harm-reduction, a1c26Does lipase tell me anything about hepatic fat on mazdutide?answered 10 Jul 2026 · liver-enzymes, mash, bloodwork26How many weeks to steady state for orforglipron on a weekly schedule?answered 1 Apr 2025 · glp1-mechanism, titration, dosing-math25Does SWB issue lot-specific documentation, or a batch certificate?answered 28 Nov 2025 · batch-testing, coa, vendor-vetting24What did the placebo arm of SURMOUNT-1 report for dizziness?answered 9 Jan 2026 · clinical-trials, harm-reduction24Why does hydrolysis accelerate at 4 °C rather than proceeding linearly?answered 26 Aug 2024 · peptide-stability, storage, hplc21How do I convert the TRIUMPH-1 hazard ratio into an absolute risk reduction?answered 25 Sept 2024 · cardiovascular, clinical-trials, dosing-math21Would you re-test orforglipron after eight weeks at minus 20 °C, or accept the original certificate?answered 27 Jul 2025 · batch-testing, peptide-stability, coa20How do I convert the SURMOUNT-5 hazard ratio into an absolute risk reduction?answered 31 Jan 2025 · cardiovascular, clinical-trials, dosing-math20Is 40 °C an acceptable storage condition for lyophilised orforglipron?answered 14 Oct 2024 · storage, peptide-stability, shelf-life20What did the placebo arm of SURMOUNT-4 report for early satiety?answered 26 May 2025 · clinical-trials, gi-side-effects20What interval makes sense for repeating lipase on cagrilintide?answered 4 May 2025 · bloodwork, harm-reduction, a1c18Does hydrolysis of retatrutide at 37 °C show up as a loss of content or of purity?answered 19 Apr 2025 · peptide-stability, content-assay, purity18How do I compare GL Biochem and QST on lead time to Sweden?answered 27 Feb 2025 · vendor-comparison, international-shipping, cold-chain16Has anyone independently verified an SWB dulaglutide batch COA?answered 10 Oct 2025 · vendor-vetting, coa, batch-testing16Is 2.5 mg/mL a sensible working concentration for liraglutide, or should I go lower?answered 19 Jul 2024 · diluent-volume, reconstitution, dosing-math15Does gallbladder risk persist once weight has stabilised?accepted · answered 20 May 2025 · gallbladder, clinical-trials, plateau15Is gallbladder wall thickening on an incidental scan meaningful here?answered 8 Mar 2026 · gallbladder, harm-reduction, gi-side-effects15When does hair thinning stop being a tolerability issue and become a clinical one?accepted · answered 19 Jun 2024 · harm-reduction, hair-loss, pancreatitis14Does holding at 1 mg for twelve weeks before escalating reduce early satiety?answered 25 Jul 2026 · titration, gi-side-effects, dose-escalation14Does hydrolysis of dulaglutide at 37 °C show up as a loss of content or of purity?answered 14 Jun 2026 · peptide-stability, content-assay, purity14Which symptoms mean stop and seek care rather than post here?answered 12 Jan 2026 · harm-reduction, pancreatitis, gi-side-effects13How long should full dissolution take, and what if it is slower?answered 17 Jul 2026 · reconstitution, lyophilisation, peptide-stability13How many units on a low-dead-space syringe is a 15 mg dose at 20 mg/mL?answered 29 Sept 2024 · dosing-math, insulin-syringe, reconstitution13What did the placebo arm of SURMOUNT-4 report for early satiety?answered 17 Jun 2025 · clinical-trials, gi-side-effects13What does 97.1% purity on a C8 column actually tell me about a liraglutide vial?answered 1 Feb 2026 · hplc, purity, coa12How much of the gross mass of a 4 mg survodutide vial is actually peptide?answered 29 Jul 2026 · content-assay, water-content, acetate-content11How do I compare WWB and FGP on lead time to Japan?answered 3 Apr 2026 · vendor-comparison, international-shipping, cold-chain11What does SELECT actually establish about semaglutide?answered 16 Feb 2026 · clinical-trials, semaglutide, cardiovascular10Do liver enzymes tell me anything useful about hepatic fat?answered 23 May 2026 · liver-enzymes, mash, bloodwork10My survodutide vial sat at room temperature for twenty-one days — is testing worth it before use?answered 30 Dec 2024 · cold-chain, peptide-stability, batch-testing9When does vomiting stop being a tolerability issue and become a clinical one?answered 16 Jul 2026 · harm-reduction, vomiting, pancreatitis8What does TRIUMPH-1 tell me about dizziness at the 8 mg dose?answered 22 Feb 2025 · clinical-trials, titration6Is there any published stability data for retatrutide at minus 80 °C?answered 7 Jun 2026 · peptide-stability, storage, clinical-trials6What interval makes sense for repeating lipase on mazdutide?answered 19 Jul 2026 · bloodwork, harm-reduction, a1c6When does vomiting stop being a tolerability issue and become a clinical one?answered 13 Jun 2026 · harm-reduction, vomiting, pancreatitis5When does reflux stop being a tolerability issue and become a clinical one?answered 26 May 2026 · harm-reduction, gi-side-effects, pancreatitis4What does SUSTAIN-6 tell me about early satiety at the 1 mg dose?answered 19 Jan 2026 · clinical-trials, gi-side-effects, titration4What is the arithmetic to convert 30 mg in 2 mL into units on a U-100 scale?answered 8 Nov 2024 · dosing-math, insulin-syringe, reconstitution3How do I get 4 units out of a vial reconstituted to 2 mg/mL without guessing?answered 13 Oct 2025 · insulin-syringe, dosing-math, diluent-volume3How many vial-days does a 10 mg vial give at 20 mg/mL on a weekly schedule?answered 17 Oct 2024 · dosing-math, cost-analysis, diluent-volume2Is a GLP-1 receptor agonist at 4 mg/mL stable enough for two weeks of multi-withdrawal use?answered 18 Mar 2026 · peptide-stability, bacteriostatic-water, shelf-life2When does reflux stop being a tolerability issue and become a clinical one?answered 23 Apr 2026 · harm-reduction, gi-side-effects, pancreatitis1Does levothyroxine absorption change with delayed gastric emptying?answered 25 Jul 2025 · thyroid, glp1-mechanism, bloodwork-2Does reflux at week seven of a GLP-1 receptor agonist usually resolve without a dose change?answered 19 May 2025 · gi-side-effects, titration-2When does constipation stop being a tolerability issue and become a clinical one?answered 21 Nov 2024 · harm-reduction, constipation, pancreatitis-2When does injection-site erythema stop being a tolerability issue and become a clinical one?answered 15 Apr 2026 · harm-reduction, injection-site-reaction, pancreatitis